Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

1.

Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects?

Moore GJ, Bebchuk JM, Hasanat K, Chen G, Seraji-Bozorgzad N, Wilds IB, Faulk MW, Koch S, Glitz DA, Jolkovsky L, Manji HK.

Biol Psychiatry. 2000 Jul 1;48(1):1-8.

PMID:
10913502
2.

Chronic treatment with lithium, but not sodium valproate, increases cortical N-acetyl-aspartate concentrations in euthymic bipolar patients.

Silverstone PH, Wu RH, O'Donnell T, Ulrich M, Asghar SJ, Hanstock CC.

Int Clin Psychopharmacol. 2003 Mar;18(2):73-9.

PMID:
12598817
5.

Preliminary in vivo evidence of increased N-acetyl-aspartate following eicosapentanoic acid treatment in patients with bipolar disorder.

Frangou S, Lewis M, Wollard J, Simmons A.

J Psychopharmacol. 2007 Jun;21(4):435-9. Epub 2006 Aug 4.

PMID:
16891338
7.

Metabonomic analysis identifies molecular changes associated with the pathophysiology and drug treatment of bipolar disorder.

Lan MJ, McLoughlin GA, Griffin JL, Tsang TM, Huang JT, Yuan P, Manji H, Holmes E, Bahn S.

Mol Psychiatry. 2009 Mar;14(3):269-79. doi: 10.1038/sj.mp.4002130. Epub 2008 Feb 5.

PMID:
18256615
8.

Lithium-induced increase in human brain grey matter.

Moore GJ, Bebchuk JM, Wilds IB, Chen G, Manji HK.

Lancet. 2000 Oct 7;356(9237):1241-2. Erratum in: Lancet 2000 Dec 16;356(9247):2104. Menji HK [corrected to Manji HK].

PMID:
11072948
9.

Lithium and valproic acid treatment effects on brain chemistry in bipolar disorder.

Friedman SD, Dager SR, Parow A, Hirashima F, Demopulos C, Stoll AL, Lyoo IK, Dunner DL, Renshaw PF.

Biol Psychiatry. 2004 Sep 1;56(5):340-8.

PMID:
15336516
10.

The human brain resonance of choline-containing compounds is similar in patients receiving lithium treatment and controls: an in vivo proton magnetic resonance spectroscopy study.

Stoll AL, Renshaw PF, Sachs GS, Guimaraes AR, Miller C, Cohen BM, Lafer B, Gonzalez RG.

Biol Psychiatry. 1992 Nov 15;32(10):944-9.

PMID:
1467379
11.

Lithium citrate for Canavan disease.

Janson CG, Assadi M, Francis J, Bilaniuk L, Shera D, Leone P.

Pediatr Neurol. 2005 Oct;33(4):235-43.

PMID:
16194720
12.

Brain lithium, N-acetyl aspartate and myo-inositol levels in older adults with bipolar disorder treated with lithium: a lithium-7 and proton magnetic resonance spectroscopy study.

Forester BP, Finn CT, Berlow YA, Wardrop M, Renshaw PF, Moore CM.

Bipolar Disord. 2008 Sep;10(6):691-700. doi: 10.1111/j.1399-5618.2008.00627.x.

13.

The effect of antidepressant treatment on N-acetyl aspartate levels of medial frontal cortex in drug-free depressed patients.

Gonul AS, Kitis O, Ozan E, Akdeniz F, Eker C, Eker OD, Vahip S.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Jan;30(1):120-5. Epub 2005 Oct 19.

PMID:
16236417
14.

A 1HMRS study of the anterior cingulate gyrus in euthymic bipolar patients.

Amaral JA, Tamada RS, Issler CK, Caetano SC, Cerri GG, de Castro CC, Lafer B.

Hum Psychopharmacol. 2006 Jun;21(4):215-20.

PMID:
16783812
15.

Glutamate as a spectroscopic marker of hippocampal structural plasticity is elevated in long-term euthymic bipolar patients on chronic lithium therapy and correlates inversely with diurnal cortisol.

Colla M, Schubert F, Bubner M, Heidenreich JO, Bajbouj M, Seifert F, Luborzewski A, Heuser I, Kronenberg G.

Mol Psychiatry. 2009 Jul;14(7):696-704, 647. doi: 10.1038/mp.2008.26. Epub 2008 Mar 18.

PMID:
18347601
16.

Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.

Yildiz-Yesiloglu A, Ankerst DP.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):969-95. Epub 2006 May 4. Review. Erratum in: Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30;31(2):591.

PMID:
16677749
17.

Neuronal pathology in the hippocampal area of patients with bipolar disorder: a study with proton magnetic resonance spectroscopic imaging.

Bertolino A, Frye M, Callicott JH, Mattay VS, Rakow R, Shelton-Repella J, Post R, Weinberger DR.

Biol Psychiatry. 2003 May 15;53(10):906-13.

PMID:
12742678
18.

Increased gray matter volume in lithium-treated bipolar disorder patients.

Sassi RB, Nicoletti M, Brambilla P, Mallinger AG, Frank E, Kupfer DJ, Keshavan MS, Soares JC.

Neurosci Lett. 2002 Aug 30;329(2):243-5.

PMID:
12165422
19.

1H MRS study of dorsolateral prefrontal cortex in healthy individuals before and after lithium administration.

Brambilla P, Stanley JA, Sassi RB, Nicoletti MA, Mallinger AG, Keshavan MS, Soares JC.

Neuropsychopharmacology. 2004 Oct;29(10):1918-24.

20.

[Neuroprotective actions of lithium].

Hashimoto R, Fujimaki K, Jeong MR, Senatorov VV, Christ L, Leeds P, Chuang DM, Takeda M.

Seishin Shinkeigaku Zasshi. 2003;105(1):81-6. Review. Japanese.

PMID:
12701214

Supplemental Content

Support Center